Vitrectomy for vitreous haemorrhage due to proliferative diabetic retinopathy in eyes with mild visual impairment.
作者信息
Anguita Rodrigo, Shah Neil, Wickam Louisa
机构信息
Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland.
出版信息
Eye (Lond). 2024 Dec;38(18):3403-3405. doi: 10.1038/s41433-024-03346-0. Epub 2024 Sep 24.
Abstract
摘要
相似文献
1
Vitrectomy for vitreous haemorrhage due to proliferative diabetic retinopathy in eyes with mild visual impairment.
Eye (Lond). 2024 Dec;38(18):3403-3405. doi: 10.1038/s41433-024-03346-0. Epub 2024 Sep 24.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
3
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Cochrane Database Syst Rev. 2023 Mar 20;3(3):CD008721. doi: 10.1002/14651858.CD008721.pub3.
4
Laser therapy for retinopathy in sickle cell disease.
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
5
A Pilot Randomized Controlled Trial Evaluating Hemostasis With Fibrin Glue During Surgery for Proliferative Diabetic Retinopathy.
Am J Ophthalmol. 2025 Apr;272:117-125. doi: 10.1016/j.ajo.2025.01.016. Epub 2025 Jan 28.
6
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Cochrane Database Syst Rev. 2011 May 11(5):CD008214. doi: 10.1002/14651858.CD008214.pub2.
7
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
8
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
9
[Analysis of the Cochrane Review: Anti-vascular Endothelial Growth Factor for Prevention of Postoperative Vitreous Cavity Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy. Cochrane Database Syst Rev. 2015;8:CD008214.].
Acta Med Port. 2017 Aug 31;30(7-8):513-516. doi: 10.20344/amp.9437.
10
Clinical Characteristics of Proliferative Diabetic Retinopathy and Outcome of Pars Plana Vitrectomy in Proliferative Diabetic Retinopathy.
J Nepal Health Res Counc. 2024 Jun 22;22(1):157-162. doi: 10.33314/jnhrc.v22i01.4958.
本文引用的文献
1
Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review.
Int J Retina Vitreous. 2020 Jun 29;6:26. doi: 10.1186/s40942-020-00230-3. eCollection 2020.
2
Complications of vitreoretinal surgery.
Curr Opin Ophthalmol. 2020 May;31(3):167-173. doi: 10.1097/ICU.0000000000000652.
3
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
Lancet. 2017 Jun 3;389(10085):2193-2203. doi: 10.1016/S0140-6736(17)31193-5. Epub 2017 May 7.
4
Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment.
Int Ophthalmol. 2005 Feb-Apr;26(1-2):15-9. doi: 10.1007/s10792-005-5389-2. Epub 2006 Jun 15.
Zotero 插件